MedTrace Logo

Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis

NCT02526303 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-02-15

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of anticoagulation in the treatment of non-occlusive portal vein thrombosis in patients with liver cirrhosis.

Conditions

Interventions

DRUG

Nadroparin Calcium and Warfarin

Warfarin (with nadroparin calcium at the first 5 days at least) until recanalization or 1 year

Sponsors & Collaborators

  • Air Force Military Medical University, China

    lead OTHER

Principal Investigators

  • Guohong Han, PhD,MD · Xijing Hospital of Digestive Diseases, Fourth Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2017-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02526303 on ClinicalTrials.gov